Millennium Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Millennium Management’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-380,359	Closed	-$5.55M	–	7118
2023 Q1	$5.55M	Buy	380,359 +241,968	+175%	+$3.42M	﹤0.01%	2514
2022 Q4	$1.01M	Sell	138,391 -120,735	-47%	-$852K	﹤0.01%	4158
2022 Q3	$1.79M	Buy	259,126 +21,518	+9%	+$161K	﹤0.01%	3848
2022 Q2	$1.66M	Sell	237,608 -23,053	-9%	-$180K	﹤0.01%	3898
2022 Q1	$2.15M	Sell	260,661 -5,595	-2%	-$50.5K	﹤0.01%	3806
2021 Q4	$2.88M	Sell	266,256 -55,340	-17%	-$598K	﹤0.01%	3425
2021 Q3	$3.89M	Buy	+321,596	New	+$3.63M	﹤0.01%	3159

Millennium Management's AMYT Position: Q2 2023 in Review

Millennium Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 380,359 shares — an estimated $5.55M sold.

Millennium Management first reported a position in AMYT in Q3 2021 and held it in 7 quarters. The position peaked at $5.55M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Millennium Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Millennium Management sold 380,359 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $5.55M.
Millennium Management first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2021 and held it in 7 quarters.
Millennium Management's Amryt Pharma plc American Depositary Shares position peaked at $5.55M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.